SOD1 and amyotrophic lateral sclerosis: Specifically, treatment of the SOD1G37R ALS mouse model with CuII(atsm), a copper-targeting compound, resulted in improvements in survival and motor function in parallel with an elevation in mutant SOD1 protein levels [14].